06/09/2016 - 9:59am

Aurobindo’s Dilaudid generic will be available in 2-, 4- and 8-mg dosage strengths. 

06/06/2016 - 2:45pm

Lupin’s generic will be available as 50- and 200-mg tablets, and as a 40-mg/mL oral suspension.

06/03/2016 - 12:31pm
Today’s launch is the fifth for Mylan in a week, having earlier launched generics of Vidaza injection and Rythmol capsules, as well as the first generics of Nuvigil and 50-mg Doryx. 
06/02/2016 - 3:37pm

Teva has introduced a generic of Novartis’ cholesterol drug Lescol. 

06/02/2016 - 11:53am

Mylan on Thursday launched two new generic products. The company rolled out its generic of Celgene’s Vidaza (azacitidine, 100 mg/vial) injection and its generic of GSK’s Rhythmol (propafenone HCl) extended-release capsules. 

06/01/2016 - 12:36pm

Mylan will have 180 days of market exclusivity for its generic of Nuvigil in 50-, 150- and 250-mg dosage strengths. 

05/31/2016 - 1:52pm

The newest member is Michael Raya, CEO of West-Ward Pharmaceuticals, which offers oral solid and injectable generics. 

05/31/2016 - 1:29pm

Technavio on Tuesday published its report on the global generic drugs market, which highlights 49 vendors expected to impact the market between 2016 and 2020. 

05/31/2016 - 1:16pm
The Economic Times is reporting that drugmaker Sun Pharma recently received a subpoena from the Department of Justice looking for information about its U.S. subsidiary’s practices in selling and marketing the company’s generics. The report noted that this is the latest move in a larger regulatory interest in generic drug prices in the last year. (Economic Times)